Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.
In patients who developed cutaneous immune-related adverse events, researchers compared outcomes for those who received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results